Literature DB >> 7885544

Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.

H L Weiner1, J H Wisoff, M E Rosenberg, M J Kupersmith, H Cohen, D Zagzag, T Shiminski-Maher, E S Flamm, F J Epstein, D C Miller.   

Abstract

Pathological and clinical data from 56 patients operated on for craniopharyngioma since 1981 were analyzed to determine the utility of dividing patients with this tumor into distinct clinical groups based on recognized pathological type and to determine the prognostic import of brain invasion. Of the tumors in the 30 adult patients, 66% were adamantinomatous, 28% were squamous papillary, and the remainder were mixed. However, of the tumors in the 26 children, 96% were adamantinomatous and none were pure squamous papillary (P < 0.01). Forty-six percent of the children compared with 17% of the adults had brain invasion (P < 0.01). Brain invasion was present in 37% of the adamantinomatous but in only 13% of the squamous papillary tumors. Seventy-seven percent of the children underwent gross total resection (GTR) compared with 27% of the adults (P < 0.01). Sixty-three percent of the squamous papillary tumors underwent GTR compared with 54% of the adamantinomatous and mixed tumors. Follow-up ranged from 7 to 187 months (mean, 49 mo). After subtotal resection, with or without radiation therapy, 58% of the tumors recurred compared with 17% recurrence after GTR (P < 0.01), with a mean time to recurrence of 34 months. In both tumor histological types, subtotal resection was associated with a higher rate of tumor recurrence compared with gross total resection. Among the subtotally resected craniopharyngiomas, 2 of the 3 (67%) squamous papillary and 11 of the 21 (52%) adamantinomatous and mixed tumors recurred. In contrast, among the totally resected tumors, none of the 5 squamous papillary and only 5 of the 25 (20%) adamantinomatous and mixed tumors recurred. There were no significant differences in Karnofsky performance status score, mortality rate, or visual and endocrine outcomes when comparing patients based on histological tumor type. When controlling for age and extent of resection, we found that brain invasion had no significant effect on recurrence rate in totally resected tumors. Based on the limited number of patients in this series, we conclude as follows. 1) Contrary to previous reports, squamous papillary craniopharyngiomas, like adamantinomatous tumors, may recur when subtotally resected. 2) For both tumor variants, the most significant factor associated with craniopharyngioma recurrence is the extent of surgical resection rather than histopathological subtype. 3) Contrary to prior hypotheses, brain invasion in totally resected tumors does not predict higher recurrence. 4) GTR is associated with a significantly lower recurrence rate and can be achieved without sacrificing functional outcome.

Entities:  

Mesh:

Year:  1994        PMID: 7885544     DOI: 10.1227/00006123-199412000-00001

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  71 in total

1.  Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.

Authors:  Shigeki Sekine; Tatsuhiro Shibata; Akiko Kokubu; Yukio Morishita; Masayuki Noguchi; Yukihiro Nakanishi; Michiie Sakamoto; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes.

Authors:  Anthe S Sterkenburg; Anika Hoffmann; Ursel Gebhardt; Monika Warmuth-Metz; Anna M M Daubenbüchel; Hermann L Müller
Journal:  Neuro Oncol       Date:  2015-04-02       Impact factor: 12.300

3.  Functional capacity and body mass index in patients with sellar masses--cross-sectional study on 403 patients diagnosed during childhood and adolescence.

Authors:  Hermann L Müller; Ursel Gebhardt; Andreas Faldum; Angela Emser; Nicole Etavard-Gorris; Reinhard Kolb; Niels Sörensen
Journal:  Childs Nerv Syst       Date:  2005-05-12       Impact factor: 1.475

Review 4.  Craniopharyngioma surgery.

Authors:  Jürgen Honegger; Marcos Tatagiba
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma.

Authors:  Zhiqiang Xia; Wenqing Liu; Shengdong Li; Ge Jia; Yuqi Zhang; Chunde Li; Zhenyu Ma; Jihui Tian; Jian Gong
Journal:  Neurochem Res       Date:  2011-08-04       Impact factor: 3.996

6.  Incidence, predictors and early post-operative course of diabetes insipidus in paediatric craniopharygioma: a comparison with adults.

Authors:  Ravindran Pratheesh; Diane Margaret A Swallow; Simon Rajaratnam; K S Jacob; Geeta Chacko; Mathew Joseph; Ari G Chacko
Journal:  Childs Nerv Syst       Date:  2013-02-06       Impact factor: 1.475

7.  Monstrous craniopharyngioma. Case presentations and term proposal.

Authors:  Humberto Trejos; Adrian Caceres; Juan L Segura
Journal:  Childs Nerv Syst       Date:  2005-03-10       Impact factor: 1.475

8.  Predictive factors for vision recovery after optic nerve decompression for chronic compressive neuropathy: systematic review and meta-analysis.

Authors:  Andrew P Carlson; Martina Stippler; Orrin Myers
Journal:  J Neurol Surg B Skull Base       Date:  2012-11-26

Review 9.  Radiation therapy in the management of pediatric craniopharyngiomas--a review.

Authors:  John A Kalapurakal
Journal:  Childs Nerv Syst       Date:  2005-06-17       Impact factor: 1.475

Review 10.  Metastatic craniopharyngioma: case report and literature review.

Authors:  Evan Mark Frangou; Jennifer Ruth Tynan; Christopher Adam Robinson; Lissa Marie Ogieglo; Aleksander Michal Vitali
Journal:  Childs Nerv Syst       Date:  2009-06-11       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.